Lind Global Fund II LP - Sep 30, 2025 SCHEDULE 13G/A Report for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX)

Filing Manager
Lind Global Fund II LP
Reporting Manager
Lind Global Fund II LP
Security
TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol
TENX
Shares outstanding
5.03M shares
Disclosed Ownership
442K shares
Ownership
8.8%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 04:10 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lind Global Fund II LP 8.8% 442K 442K 0 By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton Jeff Easton, Managing Member
Lind Global Partners II LLC 8.8% 442K 442K 0 /s/ Jeff Easton Jeff Easton, Managing Member
EASTON JEFF 8.8% 442K 442K 0 /s/ Jeff Easton Jeff Easton